Oxford Endovascular Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $10.2M

  • Investors
  • 14

Oxford Endovascular General Information

Description

Developer of a neurovascular disease device designed to treat brain aneurysms. The company uses origami engineering to prepare a laser-cut metal alloy device that can be inserted into a patient's brain using a catheter where it expands into a mesh tube that takes the shape of the blood vessel to divert blood flow away from intracranial aneurysms at risk of rupture, enabling healthcare practitioners to treat patients suffering from brain aneurysms by reducing the risk of adverse events.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • S7 Magdalen Centre, Robert Robinson Avenue
  • Oxford Science Park
  • Oxford OX4 4GA
  • England, United Kingdom
+44 07872
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • S7 Magdalen Centre, Robert Robinson Avenue
  • Oxford Science Park
  • Oxford OX4 4GA
  • England, United Kingdom
+44 07872

Oxford Endovascular Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxford Endovascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series A) 20-May-2024 $10.2M Completed Clinical Trials - General
9. Accelerator/Incubator 01-Jan-2023 Completed Clinical Trials - General
8. Later Stage VC (Series A) 08-Apr-2021 Completed Clinical Trials - General
7. Grant 16-Nov-2020 Completed Pre-Clinical Trials
6. Later Stage VC 15-Sep-2020 Completed Pre-Clinical Trials
5. Accelerator/Incubator 10-Jul-2020 Completed Pre-Clinical Trials
4. Grant 08-Jul-2019 Completed Pre-Clinical Trials
3. Seed Round 05-Apr-2018 Completed Pre-Clinical Trials
2. Seed Round 23-Dec-2015 $3.01M $3.01M Completed Startup
1. University Spin-Out 09-Sep-2015 Completed Startup
To view Oxford Endovascular’s complete valuation and funding history, request access »

Oxford Endovascular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 105,000 $0.012533 $25.07 $25.07 1x $25.07 18.88%
Ordinary 133,332 $0.012533 $18.8 $18.8 1x $18.8 23.97%
To view Oxford Endovascular’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Oxford Endovascular Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a neurovascular disease device designed to treat brain aneurysms. The company uses origami engineering to p
Therapeutic Devices
Oxford, United Kingdom
9 As of 2025

Montmorency, France
 

Alameda, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oxford Endovascular Competitors (12)

One of Oxford Endovascular’s 12 competitors is Balt, a Private Equity-Backed company based in Montmorency, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Balt Private Equity-Backed Montmorency, France
Penumbra Formerly VC-backed Alameda, CA
Boston Scientific Corporation Marlborough, MA
Evasc Formerly VC-backed Vancouver, Canada
Wallaby Medical Venture Capital-Backed Shanghai, China
You’re viewing 5 of 12 competitors. Get the full list »

Oxford Endovascular Patents

Oxford Endovascular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023304728-A1 An expandable tube for deployment within a blood vessel Pending 04-Jul-2022
EP-4551166-A1 An expandable tube for deployment within a blood vessel Pending 04-Jul-2022
GB-202209796-D0 An expandable tube for deployment within a blood vessel Inactive 04-Jul-2022
US-20260325324-A1 An expandable tube for deployment within a blood vessel Pending 04-Jul-2022
WO-2024009055-A1 An expandable tube for deployment within a blood vessel Inactive 04-Jul-2022 A61F2/852
To view Oxford Endovascular’s complete patent history, request access »

Oxford Endovascular Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oxford Endovascular Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Global Support Capital Family Office Minority
Norcliffe Capital Venture Capital Minority
Medlim Accelerator/Incubator
Additio Investment Group Venture Capital Minority
Vulpes Investment Management Family Office Minority
You’re viewing 5 of 14 investors. Get the full list »

Oxford Endovascular FAQs

  • When was Oxford Endovascular founded?

    Oxford Endovascular was founded in 2015.

  • Where is Oxford Endovascular headquartered?

    Oxford Endovascular is headquartered in Oxford, United Kingdom.

  • What is the size of Oxford Endovascular?

    Oxford Endovascular has 9 total employees.

  • What industry is Oxford Endovascular in?

    Oxford Endovascular’s primary industry is Therapeutic Devices.

  • Is Oxford Endovascular a private or public company?

    Oxford Endovascular is a Private company.

  • What is the current valuation of Oxford Endovascular?

    The current valuation of Oxford Endovascular is .

  • What is Oxford Endovascular’s current revenue?

    The current revenue for Oxford Endovascular is .

  • How much funding has Oxford Endovascular raised over time?

    Oxford Endovascular has raised $28.3M.

  • Who are Oxford Endovascular’s investors?

    Global Support Capital, Norcliffe Capital, Medlim, Additio Investment Group, and Vulpes Investment Management are 5 of 14 investors who have invested in Oxford Endovascular.

  • Who are Oxford Endovascular’s competitors?

    Balt, Penumbra, Boston Scientific, Evasc, and Wallaby Medical are some of the 12 competitors of Oxford Endovascular.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process